BTR Capital Management Has $520,000 Position in Bristol-Myers Squibb Co
BTR Capital Management raised its position in shares of Bristol-Myers Squibb Co by 8.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,565 shares of the biopharmaceutical company's stock after buying an additional 600 shares during the period.
from Biotech News
0 Comments